In 2025, paroxetine is making waves in healthcare beyond its traditional use in depression management. Once primarily prescribed as an antidepressant, this selective serotonin reuptake inhibitor (SSRI) is now being explored for broader clinical applications, ranging from post-traumatic stress disorder (PTSD) treatment to advancements in neuro